Acceptable article types

• Original Research - Original research articles focused on molecular, cellular and/or clinical perspectives of urologic tumors with significant scientific value are considered for publication. The manuscript must not exceed the maximum word count of 12,000, with no more than 15 Figures/Tables. Format: Abstract, Introduction, Materials and Methods, Results, Discussion, Conclusions.

• Reviews - Authors are encouraged to submit comprehensive reviews on broad topics of general interest in urologic oncology. Review manuscripts must be at least 4000 words (excluding references) with a minimum of 80 references. Reviews should include 1-6 figures, diagrams or schematics. Format: Abstract, Introduction, Subsections relevant for the subject, Discussion or Conclusions.

• Clinical Trial - Clinical trial articles should describe interventional studies related to urologic oncology, including pilot studies, safety and efficacy trials, surrogate endpoint studies, and proof-of concept studies. There is no strict restriction for number of words, tables and Figures. Format: Abstract, Introduction, Materials and Methods, Results, Discussion. All clinical trials must be registered in a public trials registry prior to be considered for publication, and authors must comply with the Consolidated Standards of Reporting Trials (CONSORT).

• Systematic Review - Systematic Review articles should synthesize previous research using well-defined methods to identify, categorize, analyze and report aggregated evidence on a specific topic. This category includes meta-syntheses, meta-analyses, mapping reviews, scoping reviews, systematic reviews, and systematic reviews with a meta-analysis. The maximum word count is 12,000 with no more than 15 Figures/Tables. Systematic Review article must clearly define the research question using the PICOS framework (population, interventions, comparators, outcomes and study designs) In addition, it should conform to the reporting guidelines (e.g., PRISMA, Cochrane, Campbell), and include the PRISMA flow diagram http://prisma-statement.org/prismastatement/flowdiagram.aspx. Format: Abstract, Introduction, Methods, Results, Discussion, Conclusion.

• Mini Review - Mini reviews provide focused summaries of a current area of investigation and its recent developments. They should offer a succinct and clear summary of the topic, allowing readers to get up-to-date on new developments and/or emerging concepts, as well as discuss the following: Different schools of thought or controversies, Current research gaps, and Potential future developments in the field. The manuscript must not exceed the maximum word count of 3,000 with no more than 2 Figures/Tables. Format: Abstract, Introduction, Subsections relevant for the subject, Discussion or Conclusions.

• Case Reports - Case Reports highlight unique or unexpected urologic oncology cases, including rare diagnosis, treatment outcome, or clinical course. Case Report must not exceed word count of 3,000 with no more than 4 display items (figures, tables, or videos). Authors should follow the CARE guidelines and submit a completed CARE checklist as a supplementary file (template available here: https://www.care-statement.org/checklist). Format: Abstract, Introduction, Case description, A figure or table showcasing a timeline with relevant data from the episode of care, Diagnostic assessment, Details on the therapeutic intervention, Follow-up and outcomes, as specified in the CARE guidelines, Discussion. Written informed consent from the patients (or their legal representatives) should be provided for the publication. All Case Reports should carry the title “Case Report: ‘area of focus’”. More information on CARE guidelines are available here: https://www.care-statement.org/.

• Perspectives/ Opinions - Perspective articles present viewpoints on specific areas of investigation, covering current advances and future directions; Clear presentation of the authors’ perspective; Accurate presentation and citations of other authors’ work; May include original data as well as personal insights and opinions. Maximum word count for Perspective/Opinions are 3,000 with no more than 2 Figures/Tables. Format: Abstract, Introduction, Subsections relevant for the subject, Discussion.

• Letters or Comments - Brief letters or Commentaries provide critical feedback on previously published articles in AUO. Brief letters or commentaries are welcomed with no more than 1000 words and two figures or tables.
  

Plagiarism

All submitted manuscript are checked for originality following the COPE guidelines. Manuscript with plagiarism including any form of copying (text, images, data, and ideas) without a proper attribution will result in rejection during the peer-review process or retraction after publication. The corresponding author must sign a Declaration of Original Work form to state that their submitted work has not been previously published. Click here to see journal’s anti-plagiarism policy.

Conflict of interest

Conflict of interests occur when authors, reviewers or editors have financial (e.g., employment, consultancies, stock ownership, honoraria, paid expert testimony) or personal relationships that may influence their scientific judgment. These financial or personal relationships and academic competition must be declared. The authors can declare conflicts of interest and sources of financial support as acknowledgment. The authors must provide conflicts of interest statement at the end of main text, even if there is nothing to disclose. Click here to see our policies on conflict of interest.

Human and animal rights ethical statement

All studies involving human participants and/or animal research must be approved by institutional review board or equivalent ethics committee(s). The name of the approving ethics board must be included in the manuscript. Studies involving human participants must obtain informed consent (or the reason for lack of consent must be explained, e.g. the data were analyzed anonymously) and all clinical investigations must comply with the principles expressed in the Declaration of Helsinki. Studies involving animal experiments must include an Ethics Statement at the beginning of the Methods section stating: "Investigation has been conducted in accordance with ethical standards, the Declaration of Helsinki, and national and international guidelines, and was approved by the [authors' institutional review board]".

Informed consent

Patients involved in the research must provide informed consent to ensure their privacy rights are protected. The manuscript should clearly state whether informed consent was obtained from all patients.